Origins of Cancer Immunotherapy, ft. Dr. Steven Rosenberg
The ImmunoVerse™
00:00
How will cancer immunotherapy evolve in 5–10 years?
Steven Rosenberg predicts major advances in identifying and expanding T cells as living drugs, broader efficacy against solid epithelial cancers, and multiple complementary approaches.
Transcript
Play full episode
